approval
saveSUMATRIPTAN SUCCINATE — FDA approval
community read0 votes
Sponsor: ALEMBIC. Form: INJECTABLE. Route: SUBCUTANEOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalIMITREX (SUMATRIPTAN) — FDA approvalDec 9, 2025 · 296d ago
- approvalIMITREX (SUMATRIPTAN SUCCINATE) — FDA approvalDec 9, 2025 · 296d ago
- approvalIMITREX STATDOSE (SUMATRIPTAN SUCCINATE) — FDA approvalDec 9, 2025 · 296d ago
- approvalIMITREX STATDOSE (SUMATRIPTAN SUCCINATE) — FDA approvalDec 20, 2021 · 1746d ago
- approvalIMITREX (SUMATRIPTAN SUCCINATE) — FDA approvalMar 23, 2021 · 2018d ago
- approvalIMITREX STATDOSE (SUMATRIPTAN SUCCINATE) — FDA approvalMar 23, 2021 · 2018d ago
- approvalIMITREX STATDOSE (SUMATRIPTAN SUCCINATE) — FDA approvalJul 17, 2018 · 2998d ago
- approvalIMITREX STATDOSE (SUMATRIPTAN SUCCINATE) — FDA approvalDec 14, 2017 · 3213d ago
same company · ±60 days · 6
- approvalDASATINIB: DASATINIB — FDA approvalNov 6, 2025
- approvalBUPROPION HYDROCHLORIDE: BUPROPION HYDROCHLORIDE — FDA approvalNov 6, 2025
- approvaldexlansoprazole DR: DEXLANSOPRAZOLE — FDA approvalNov 12, 2025
- approvalDILTIAZEM HYDROCHLORIDE: DILTIAZEM HYDROCHLORIDE — FDA approvalNov 14, 2025
- approvalTICAGRELOR: TICAGRELOR — FDA approvalOct 28, 2025
- approvalropinirole hydrochloride ER: ROPINIROLE HYDROCHLORIDE — FDA approvalNov 19, 2025
comments(0)
5-min edit window · permanent after that